dlbcl
Showing NaN - NaN of 4
Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in United Kingdom, United States (AUTO3)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- +3 more
- AUTO3
-
Duarte, California
- +10 more
Oct 19, 2022
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL Trial in
Enrolling by invitation
- Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
- +4 more
- AUTO CAR T cell therapy
-
London, United Kingdom
- +3 more
Feb 2, 2022
DLBCL, Richter Syndrome Trial in United Kingdom, United States (acalabrutinib, vistusertib)
Terminated
- DLBCL
- Richter Syndrome
-
Fairway, Kansas
- +10 more
Jan 4, 2021